CEVARETIGENE RITOPARVOVEC
UNII KVF2UY1OR4

Substance Identification & Data

This profile provides standardized clinical and technical data for Cevaretigene Ritoparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KVF2UY1OR4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2247971-00-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KVF2UY1OR4

CAS Registry Number

2247971-00-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CEVARETIGENE RITOPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175755

National Cancer Institute reference terminology for clinical and research data.

INN ID

11368

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-111

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cevaretigene Ritoparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CEVARETIGENE RITOPARVOVEC

Common Names & Synonyms

AAV2/5-OPTIRPE65

AAV2/5-RPE65P/OPTIRPE65

CEVARETIGENE RITOPARVOVEC [INN]

CEVARETIGENE RITOPARVOVEC [USAN]

DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS 5 VECTOR AAV2/5-OPTIRPE65 HUMAN ALL-TRANS-RETINYL ESTER ISOMEROHYDROLASE CODON-OPTIMIZED GENE RPE65 PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS)

Technical Codes

A001

External Clinical & Regulatory Resources

Previous UNIIKVE6FF6B6G

Next UNIIKVF4175O54